| Document Date: 2014-11-13 10:45:33
Open Document File Size: 1,65 MBShare Result on Facebook
City Cambridge / London / Oxford / / Company Bayer Technology Services / AstraZeneca / Programme / / Country Germany / Japan / United States / / Currency EUR / / Facility University of Leipzig / Institute of Biochemistry / University of Freiburg / / IndustryTerm pharmaceutical target identification / potential applications / potential solutions / therapies of steatosis and related diseases / pharmaceutical / clinically-relevant applications / / MedicalCondition common disease / fatty liver disease / disease / inflammatory process / cardiovascular disease / related diseases / diseases / illness / inflammation / liver steatosis / / Organization Institute of Biochemistry / VLN / University of Leipzig / German Federal Ministry of Research / Mannheim Medical Faculty / University of Freiburg / / Person Steven Dooley / Rolf Gebhardt / Jens Timmer / Sabine Louet Crucially / Adriano Henney / Lars Küpfer / / Position team member / TACKLE / Deputy Director / Director / specialist / / RadioProgram LEADING THE WAY / / Technology drug discovery / bioinformatics / SIMULATION / / URL www.isbe.eu / /
SocialTag |
BIOGRAPHY PUBLICLY-FUNDED GERMAN FLAGSHIP INITIATIVE IS LEADING THE WAY IN LIVER RESEARCH SINCE ITS BEGINNING IN APRIL 2010, THE VIRTUAL LIVER NETWORK HAS ENGAGED